Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Coronary Disease and PON1[original query] |
|---|
| Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. Journal of molecular medicine (Berlin, Germany) 2001 Aug 79 (8): 457-63. Leviev I, Righetti A, James R |
| Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families. The Journal of clinical endocrinology and metabolism 2002 Mar 87 (3): 1268-73. Deakin Sara, Leviev Ilia, Nicaud Viviane, Brulhart Meynet Marie-Claude, Tiret Laurence, James Richard W, |
| Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I. Journal of lipid research 2006 Mar 47 (3): 515-20. Blatter Garin Marie-Claude, Moren Xenia, James Richard |
| Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT study. Disease markers 2012 Jan 33 (2): 2. Mackness B, Marsillach J, Elkeles RS, Godsland IF, Feher MD, Rubens MB, Flather MD, Humphries SE, Cooper J, Mackness M |
| Paraoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibility. Biochemical genetics 2014 Dec 52 (11-12): 509-23. McDaniel Chiquita Y, Dail Mary Beth, Wills Robert W, Chambers Howard W, Chambers Janice |
- Page last reviewed:Feb 1, 2024
- Content source: